Synthesis of novel orthogonally protected 1,3,4-thiadiazole and 1,3,4-oxadiazole tethered dipeptide mimetics is described. Both the heterocycles are prepared via a set of diacylhydrazines derived from amino acids. 1,3,4-Thiadiazoles are synthesized by dehydrosulfurization using Lawesson's reagent while 1,3,4-oxadiazoles are obtained by EDC mediated cyclodehydration.
The changes in conformation, polarity and metabolic stability generated by structural modifications of peptide backbone have prompted the synthesis of several new classes of peptide mimics, which contain unnatural linkages as replacements for the native peptide bonds. These molecules have shown enhanced potency, specificity and oral bioavailability than the natural peptides and are considered to be potential candidates in drug discovery. 1 One such important class of molecules is peptides substituted with heterocycles, also referred to as peptide heterocycles. The heterocyclic unit in these molecules can introduce conformational constraints to the structure that enhances the activity and alters the structure-activity-relationships. 2 Thus several heterocycles such as 1,2,3-and 1,2,4-triazole, 3 oxazole, 4 thiazole, and tetrazole, 5 have been inserted en route to the design of new peptidomimetics. 2-Alkyl amino-1,3,4-oxadiazole based peptidomimetics have been described earlier by our group. 6 In view of the above and as a part of our ongoing work on the synthesis of amino acids and peptide derivatives containing heterocyclic units, 7 we herein report the facile synthesis of novel N,N 0 -orthogonally protected 1,3,4-thiadiazolo-and 1,3,4-oxadiazolo-substituted peptides. Substances bearing these heterocycles have attracted significant interest in medicinal and bio-organic chemistry. For example, thiadiazole derivatives are known to be potent aminopeptidase inhibitors 8 and metalloprotease inhibitors. 9 Similarly, biologically relevant entities containing the oxadiazole motif include HIV integrase inhibitors and the angiogenesis inhibitors.
10,11
Although numerous reports are available for the construction of 1,2,4-oxadiazole peptidomimetics, 7a,12 the reports on the synthesis of 1,3,4-oxadiazole and 1,3,4- 20 The present report deals with the synthesis of 1,3,4-thiadiazole and oxadiazole based peptidomimetics through a facile route which involves N,N 0 -di-a-aminoacyl hydrazines as common precursors.
The required diacylhydrazines were synthesized as follows. Initially, the N-Boc/Z-protected amino acids were converted to their corresponding hydrazides 1 following the reported protocol.
21 NAcylation of the latter with a second amino acid to furnish the diacylhydrazine was achieved by the treatment with N-Boc/Z protected a-amino acid fluorides. Unlike amino acid chlorides, Nurethane protected amino acid fluorides are excellent coupling reagents for both solution and solid phase synthesis. Their most impressive application is in the synthesis of extremely hindered dipeptides. 22 The N-protected amino acid fluorides 2 used were prepared through the reaction of protected amino acids with Deoxo-fluor 23 in the presence of N-methylmorpholine (NMM). In a typical example, Fmoc-Ala-F was treated with Boc-Phe-NHNH 2 in dry CH 2 Cl 2 at room temperature for 30 min. The resulting peptidyl diacylhydrazine 3b was isolated and purified (Scheme 1). 24 The list of N-protected diacylhydrazines prepared is summarized in Table 1 .
Lawesson and co-workers, have described the thionation of 1,2-diacylhydrazines with 2,4-bis(4-methoxypheny1)-1,2,3,4-dithiadiphosphetane (Lawesson's reagent, LR), followed by spontaneous ring closure through dehydrosulfurization leading to the formation of thiadiazole ring. 25 Their study dealt mainly with the preparation of dialkyl thiadiazoles. We sought to extend this route for the synthesis of thiadiazole tethered N,N 0 -orthogonally protected dipeptidomimetics 4 through the direct cyclization of diacylhydrazines (without the requirement of a separate thionation step).
In a typical experiment, the diacylhydrazine 3b was refluxed with LR in THF for 3 h which yielded the 1,3,4-thiadiazolo-dipeptide 4b. The same protocol was used to prepare several differentially protected 1,3,4-thiadiazolo-peptides 4a-j containing N,N 0 -orthogonal amino protecting groups (Scheme 2, Table 2 , Fig 1) . 26 The synthesis of oxadiazolo-peptides 5a-j was then undertaken. 1,3,4- 35 Therefore, we focused on employing ethyl-3-(3-dimethylaminoprophyl)carbodiimide (EDC) as cyclodehydrating agent. EDC was particularly attractive because of easy handling, simplicity associated to the workup of the product, efficiency in terms of product yield and the familiarity with its use in peptide and peptidomimetic(s) synthesis. In a typical procedure, the reaction of the N-Boc, N 0 -Fmoc protected diacylhydrazine 3b in dry CH 2 Cl 2 was refluxed in the presence of 1 equiv of EDC and 1.5 equiv of triethylamine (TEA) for 3 h which resulted in the formation of 1,3,4-oxadiazole derivative 5b in almost quantitative yield. Extending the protocol further, a series of Boc, Z and Fmoc-protected 1,3,4-oxadiazole containing dipeptidomimetics 5a-j were prepared starting from the corresponding diacylhydrazides (Scheme 2, Table 2 , Fig. 1 ).
36
Using the above protocols, the 1,3,4-thiadiazole/oxadiazole moieties were also inserted between an orthogonally protected sterically hindered dipeptide Z-Aib-CONHNHCO-Aib-Boc (Fig. 1,  4i and 5i) . In another example Z-Ala-CONHNH 2 was coupled to C 6 H 5 COF and subsequently cyclized into 1,3,4-thiadiazole/oxadiazole derivative (Fig. 1, 4j and 5j) .
Finally, the possibility of racemization during the synthesis of title thiadiazoles and oxadiazoles was studied by determination of the chiral purity of the samples of 4b, 5b, 4c, and 5c prepared via the present protocol by means of 1 H NMR and HPLC analyses. 37, 38 The studies revealed that the tested samples were optically homogenous, and further the described protocol is free from racemization.
In conclusion, the current protocol is a simple and straightforward route for the insertion of 1,3,4-thiadiazolo-and 1,3,4-oxadiazolo-units into peptides. The synthesis makes use of amino acid substituted diacylhydrazines as common intermediate which on treatment with Lawesson's reagent and EDC furnishes the thiadiazolyl and oxadiazolyl compounds, respectively. The procedures give good yields and good purities with no detectable enantiomerization. To a solution of hydrazide 1 (10 mmol), in DCM (10 mL) was added a solution of acid fluoride 2 (10 mmol) in DCM (5 mL) and the mixture was stirred at rt for 30 min or till the completion of the reaction (TLC analysis). The solvent was evaporated under reduced pressure and the residue was extracted with EtOAc. The organic layer was washed with citric acid (10%, 10 mL Â 2), Na 2 CO 3 (10%, 10 mL Â 2), water (10 mL) and brine (10 mL) and finally dried over anhydrous Na 2 SO 4 . The solvent was removed under reduced pressure and the resulting crude compound was purified by column chromatography. Spectroscopic data for 3b: 2, 28.7, 33.2, 42.8, 48.3, 53.4, 64.6, 79.8, 126.1, 126.7, 127.6, 128.0, 128.1, 128.5, 128.9, 137.6, 140.3, 143.1, 155.3, 155.8, To a solution of diacylhydrazine 3 (10 mmol) in THF, Lawesson's reagent (2.85 g, 15 mmol) was added and the solution was refluxed for 3 h. After completion of the reaction (monitored by TLC), the reaction mixture was filtered and the solvent was removed in vacuo. The resulting crude compound was purified by column chromatography (EtOAc/n-hexane, 2:8) to afford analytically pure product. Spectroscopic data for 4i:
1 H NMR (CDCl 3 , 300 MHz,) d 1.40 (s, 9H), 1.55 (s, 12H), 5.08 (s, 2H), 6.18 (br, 1H), 6.78 (br, 1H), 7.08-7.19 (m, 5H); 13 C NMR (CDCl 3 , 75 MHz) d 28. 1, 28.5, 48.6, 55.9, 64.6, 80.2, 127.2, 127.4, 127.9, 135.5, 155.6, 155.8, 167.9, 169.5 To a solution of diacylhydrazide 3 (10 mmol) in DCM, EDC (1.91 g, 10 mmol) and TEA (2.09 mL, 15 mmol) were added and the reaction mixture was refluxed for 3 h (monitored by TLC). The solvent was removed in vacuo and the crude was dissolved in EtOAc (10 mL Â 2) and it was washed successively with citric acid (10%, 10 mL Â 2), Na 2 CO 3 (5%, 10 mL), water (2 Â 10 mL) and brine (10 mL) and dried over anhydrous Na 2 SO 4 . The solvent was removed under vacuum and purified by column chromatography (EtOAc/n-hexane, 2:8) to afford pure oxadiazole. Spectroscopic data for 5e: 2, 17.2, 28.7, 29.0, 33.7, 48.3, 51.0, 64.1, 79.9, 126.8, 127.3, 128.2, 139.8, 154.9, 155.8, 166.8, 169.7 .55 min for 4b and at 9.43 min for 4c were observed, whereas the corresponding enantiopure 1,3,4-oxadiazoles 5b and 5c showed single retention times at 11.73, 11.67 min, respectively.
